| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
A selective antagonist of P2X purinoceptor; can inhibit ATP-mediated GPCR signaling which may intersect with GPR75 pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which in turn would inhibit the MAPK/ERK pathway, often downstream of GPCR activation, including pathways GPR75 may engage. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting cytoskeletal rearrangements and cell motility that could be downstream of GPR75 signaling. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
An inhibitor of Raf-1 kinase, potentially affecting MAPK pathway activation downstream of GPR75 activation. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A potent inhibitor of protein kinase C, which may be activated by GPR75 signaling through Gq proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, which could affect the PI3K/Akt pathway, often downstream of GPCR activity, possibly including GPR75. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
A non-selective antagonist of P2 purinergic receptors, could inhibit GPCR signaling pathways that may be modulated by GPR75. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAPK, could affect inflammatory responses that GPR75 may be involved with. | ||||||